The transcatheter aortic valve replacement (TAVR) market size was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period (2019-2026).
The transcatheter aortic valve replacement (TAVR) market is driven by several growth factors such as rising prevalence of cardiovascular disorders such as heart failure (HF), coronary artery diseases (CAD), and hypertension. Cardiovascular diseases (CVDs) cause improper functioning of aortic valves, hence fuelling the demand for efficient valve replacement procedure.
Increasing advancement in technology, new product launch, rising funding for research & development activities, increasing collaboration and mergers by major players are also some of the factors boosting the growth of the TAVR market globally.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
